Shaban Athuman
/
VPM News
Almost 40% of the county’s 2024 homicides were from instances of IPV.
Spotlight on VPM Original Content
RVA's Got Issues
VPM 60th Anniversary
Virginia News
NPR News
Virginia News
-
Most of the money being cut comes from capital projects at public universities. -
Problems included over 150 checks sent for parcels that did not exist.
-
The 31-mile extension would run from Pittsylvania County into North Carolina.
-
The Creative ReUse Center's volunteers altered dresses and suits for the LGBTQ+ prom.
-
Recent data from the Richmond Fed also points to slowing sectors.
-
The transfer comes at no cost to the school division.
NPR News
-
The U.S. Centers for Disease Control and Prevention updated the numbers of measles cases in the country on Friday. Here's what they say and what it means for public health in the U.S.
-
Vice President Vance said the fighting between India and Pakistan was "fundamentally none of our business." Experts say the U.S. used to work hard to de-escalate crises between the nuclear states.
-
Pope Leo XIV is seen as a centrist who shares his predecessor's progressive views on certain social issues. Here's what we know so far.
-
NPR has learned that rules must now be vetted by the White House and that the administration is drafting an executive order that could loosen radiation limits.
-
Trump's administration said they want tariffs to boost US manufacturing, and most Americans want more factory jobs here. But what makes us nostalgic for factory work?
Arts & Culture
- Tara Roberts helps scuba divers uncover slave shipwrecks
- New Burying Ground honors enslaved labor at University of Richmond
- Museums, libraries and cultural groups grapple with federal humanities cuts
- ‘Idleness and boredom’: Virginia juvenile justice system strained by staffing shortages
Listen to VPM
- VPM Daily Newscast: Richmond City Council finalizes $3 billion FY26 budget
- Guest conductor Michael Repper leads the Richmond Symphony in Berlioz's Symphonie Fantastique
- VPM Daily Newscast: ‘Catalyst’ UVA Manning Institute for Biotechnology
- Interview: Keep finds the new normal